disease-prevention

Documents about disease-prevention

• Ulcerative Colitis Relapse Prevention Trial, Hypnosis#918123ClinicalTrials.gov
• Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients#991866ClinicalTrials.gov
• Comparison of Dexmedetomidine and Meperidine for the Prevention of Shivering Following Coronary Artery Bypass Graft#994791ClinicalTrials.gov
• Repeated Low-Level Red-Light Therapy for Shortening Axial Length#1009940ClinicalTrials.gov
• Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)#1044660ClinicalTrials.gov
• 42 U.S.C. § 242c — Appointment and authority of the Director of the Centers for Disease Control and Prevention#595427US Code (LII)
• WomenFocused Education in CArdiac REhabilitation (WECARE) Pilot RCT#873653ClinicalTrials.gov
• Pharmacological blood pressure-lowering for prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual participant data meta-analysis of 46 randomised controlled trials#221885Ora Oxford University Research
• Evaluation of the Use of a Remote Monitoring and Follow-up Option for Patients With Chronic Obstructive Pulmonary Disease (BOREAL)#896893ClinicalTrials.gov
• Pemanfaatan Data Mining untuk Klasifikasi Penyakit Daun pada Tebu dan Cara Pencegahan Penyakit dengan Metode Algoritma K-Nearest Neighbors#1003270Bridge : Jurnal Publikasi Sistem Informasi dan Telekomunikasi
• HHSD2002008F25830 — LOCKHEED MARTIN SERVICES, LLC — Department of Health and Human Services ($46,566,666)#601728USAspending
• HHSD2002007F19557 — LOCKHEED MARTIN SERVICES, LLC — Department of Health and Human Services ($23,442,075)#602520USAspending
• 75D30125F20706 — MCP COMPUTER PRODUCTS INC — Department of Health and Human Services ($23,198,736)#602537USAspending
• HHSD200200928656C — SANOFI VACCINES US INC. — Department of Health and Human Services ($737,348,871)#605604USAspending
• HHSD200201033940C — SANOFI VACCINES US INC. — Department of Health and Human Services ($709,203,249)#605685USAspending
• Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission#915731ClinicalTrials.gov
• Implementation and evaluation of a pragmatic community streptococcal treatment programme to improve rheumatic heart disease primary prevention in Uganda.#25608NCBI PubMed Central
• Advancements in AI-Enhanced OCT Imaging for Early Disease Detection and Prevention in Aging Populations#73595PhilArchive
• Cutaneous Leishmaniasis in Tigray, North Ethiopia: The Communities Awareness, Perceptions, Treatment-seeking and Prevention Practices in Disease Endemic Areas.#134320bioRxiv / medRxiv
• A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults#172379ClinicalTrials.gov
• Development of a Panvascular Health Promotion and Risk Stratification Tool for Community Screening: Grounded in Four-Level Disease Prevention Theory.#196020NCBI PubMed Central
• Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age#217084ClinicalTrials.gov
• Global level of functioning among unemployed individuals diagnosed with depression#219893Springer Nature OA
• m-Lifestyle Intervention for Employees (m-LIfE): protocol for a pilot cluster randomized controlled trial on cardiovascular disease prevention strategies.#242170NCBI PubMed Central
• A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months#261335ClinicalTrials.gov
• Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .#363656ClinicalTrials.gov
• The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine#363668ClinicalTrials.gov
• Determinants of Healthcare Providers’ Notification, Prevention and Perception Scores Under the Notifiable Disease Surveillance System (NDSS) in Jazan, Saudi Arabia.#368139NCBI PubMed Central
• Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy#668900ClinicalTrials.gov
• Immune Response Study of Influenza Vaccine#802747ClinicalTrials.gov
• Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old#810530ClinicalTrials.gov
• The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination#825479ClinicalTrials.gov
• The Bern Rehab Registry#832672ClinicalTrials.gov
• Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)#881878ClinicalTrials.gov
• Children Education and Cardiovascular Risk Reduction in Their Parents#893729ClinicalTrials.gov
• Fall Detection and Prevention for Memory Care Through Real-time Artificial Intelligence Applied to Video#904157ClinicalTrials.gov
• Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation#913109ClinicalTrials.gov
• Speech Pattern Evaluation and Analysis for Knowledge of AD#966772ClinicalTrials.gov
• TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection#969978ClinicalTrials.gov
• HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission#980476ClinicalTrials.gov
• 42 U.S.C. § 300b-5 — Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment#594907US Code (LII)
• HHSD200201458150C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,480,605,084)#604812USAspending
• HHSD200201793273C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,453,663,190)#604824USAspending
• HHSD200201354509C — MERCK SHARP & DOHME LLC — Department of Health and Human Services ($1,372,607,194)#604861USAspending
• HHSD200201250133C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,369,650,661)#604862USAspending
• HHSD200201034037C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,327,365,536)#604899USAspending
• HHSD200200929370C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,319,368,887)#604906USAspending
• HHSD200200720306C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,317,743,050)#604907USAspending
• HHSD200201138200C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,273,848,674)#604937USAspending
• HHSD200200824718C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,180,245,725)#604998USAspending